Gene: ERLEC1
Official Full Name: endoplasmic reticulum lectin 1provided by HGNC
Gene Summary: This gene encodes a resident endoplasmic reticulum (ER) protein that functions in N-glycan recognition. This protein is thought to be involved in ER-associated degradation via its interaction with the membrane-associated ubiquitin ligase complex. It also functions as a regulator of multiple cellular stress-response pathways in a manner that promotes metastatic cell survival. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 21. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27695 | ERLEC1 Knockout cell line (HeLa) | Human | ERLEC1 | 1:3~1:6 | Negative | Online Inquiry |
KO27696 | ERLEC1 Knockout cell line (HCT 116) | Human | ERLEC1 | 1:2~1:4 | Negative | Online Inquiry |
KO27697 | ERLEC1 Knockout cell line (HEK293) | Human | ERLEC1 | 1:3~1:6 | Negative | Online Inquiry |
KO27698 | ERLEC1 Knockout cell line (A549) | Human | ERLEC1 | 1:3~1:4 | Negative | Online Inquiry |
ERLEC1 Gene Knockout Cell Lines are engineered cellular models that harbor targeted deletions of the ERLEC1 gene, providing a powerful tool for researchers in the fields of genetics, cell biology, and molecular medicine. These knockout lines facilitate the study of ERLEC1's roles in various physiological processes and disease states, particularly in relation to cellular responses to stress and inflammatory signaling pathways.
The primary function of these cell lines is to enable the elucidation of ERLEC1's contributions to cell signaling and metabolism. By completely knocking out the gene, researchers can assess changes in cellular behavior, gene expression, and protein interactions that may arise from the absence of ERLEC1, allowing for a comprehensive understanding of its biological significance. This mechanistic insight can drive discoveries in areas such as cancer research, neurodegenerative diseases, and metabolic disorders.
In both research and clinical settings, ERLEC1 Gene Knockout Cell Lines hold substantial scientific value, offering a platform for drug discovery, biomarker identification, and the development of targeted therapies. The ability to draw mechanistic correlations between ERLEC1 function and various disease pathways provides a competitive edge in uncovering new therapeutic targets.
Compared to traditional knockout models, our ERLEC1 Gene Knockout Cell Lines offer enhanced specificity and robustness, giving researchers confidence in their experimental outcomes. They are pre-validated for consistent performance across experiments, which streamlines workflow and increases the reproducibility of results.
We understand the challenges faced by researchers and clinicians in their quest for reliable biological tools. Our expertise in cell line engineering ensures that the ERLEC1 Gene Knockout Cell Lines are not only scientifically sound but also tailored to meet the needs of modern research environments. Choosing our product means investing in cutting-edge technology that accelerates discovery and innovation in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.